Kangmei Pharmaceutical Co., Ltd. announced that at the Annual General Meeting held on 2 June 2015 approved the election of Ma Xingtian, Dongjin, Li Shi and Ma Hanyao as directors and Jiang Zhenping as independent director.

The company also approved the cash dividend of CNY 3.2 per ten shares (tax included) for the year 2014.